GLASGOW, Scotland--(BUSINESS WIRE)--Dxcover Limited, a clinical-stage liquid biopsy company pioneering Multi-Omic Spectral Analysis for early detection of cancer, today announced that findings from a ...

CIC bioGUNE leads a study showing that multi-omic data can identify silent and stable risk profiles in healthy individuals The study, conducted using local cohorts from the Basque Country, ...

Scientists gain a deeper understanding of different cancers when they analyze a range of omics data types. New tools like multiplexed imaging provide functionality for studying omics data in its ...

An analysis of more than 100,000 colorectal cancer cases and 154,000 healthy controls published in Nature Genetics uncovered hundreds of signals that may serve as new treatment and prevention targets.

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Every day, scientists are conducting groundbreaking research to gain insight into the world’s most complex and life-threatening diseases and bring effective treatments to patients around the globe.

Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA Multiple myeloma (MM) is a genetically heterogeneous malignancy characterized by variable treatment responses.

Combination of atezolizumab and pirfenidone in second-line and beyond NSCLC: A phase I/II study. Background: Immune checkpoint inhibitors (ICI) have demonstrated efficacy in a wide variety of cancers.

Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally ...